La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Xintec Bilan de santé

Santé financière contrôle des critères 6/6

Xintec possède un total de capitaux propres de NT$8.1B et une dette totale de NT$388.5M, ce qui porte son ratio d'endettement à 4.8%. Son actif total et son passif total sont NT$11.1B et de NT$3.1B. L'EBIT de Xintec est NT$1.9B ce qui fait que son ratio de couverture des intérêts -37.2. Elle dispose de liquidités et de placements à court terme de NT$4.4B.

Informations clés

4.8%

Ratio d'endettement

NT$388.46m

Dette

Ratio de couverture des intérêts	-37.2x
Argent liquide	NT$4.42b
Fonds propres	NT$8.06b
Total du passif	NT$3.07b
Total des actifs	NT$11.13b

Mises à jour récentes de la santé financière

Is Xintec (GTSM:3374) Using Too Much Debt?

Dec 30

Recent updates

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Apr 16

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Mar 29

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 11

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

Feb 18

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Dec 15

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Nov 30

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 3374 ( NT$6.1B ) dépassent ses passifs à court terme ( NT$2.1B ).

Passif à long terme: Les actifs à court terme de 3374 ( NT$6.1B ) dépassent ses passifs à long terme ( NT$954.9M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 3374 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 3374 a été réduit de 75.4% à 4.8% au cours des 5 dernières années.

Couverture de la dette: La dette de 3374 est bien couverte par le flux de trésorerie opérationnel ( 536.6% ).

Couverture des intérêts: 3374 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Xintec Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Is Xintec (GTSM:3374) Using Too Much Debt?

Recent updates

Investor sentiment deteriorates as stock falls 16%

Price target increased by 45% to NT$186

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Xintec Inc. to Report Q2, 2024 Results on Aug 08, 2024

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Upcoming dividend of NT$2.00 per share

Investor sentiment improves as stock rises 23%

Dividend of NT$2.00 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Xintec Inc. to Report Q1, 2024 Results on May 09, 2024

Xintec Inc., Annual General Meeting, May 30, 2024

Third quarter 2023 earnings released: EPS: NT$1.89 (vs NT$2.22 in 3Q 2022)

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of NT$3.00 per share at 2.3% yield

Investor sentiment improves as stock rises 22%

Xintec Inc. Appoints Mike Liang as Independent Director

Price target decreased by 7.4% to NT$119

Full year 2022 earnings: EPS exceeds analyst expectations

Xintec Inc. to Report Q4, 2022 Results on Feb 09, 2023

Price target decreased to NT$118

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase by 26%

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of NT$3.00 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to NT$117

Insufficient new directors

Consensus EPS estimates fall by 23%

Full year 2021 earnings: EPS and revenues miss analyst expectations

Xintec Inc., Annual General Meeting, May 26, 2022

Xintec Inc. to Report Q4, 2021 Results on Feb 10, 2022

Insufficient new directors

Insufficient new directors

Investor sentiment improved over the past week

Upcoming dividend of NT$2.50 per share

Investor sentiment deteriorated over the past week

Price target decreased to NT$166

Consensus EPS estimates fall to NT$7.08

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Is It Worth Buying Xintec Inc. (GTSM:3374) For Its 1.5% Dividend Yield?

Consensus EPS estimates fall to NT$8.54

Xintec (GTSM:3374) Is Achieving High Returns On Its Capital

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

Xintec Inc.'s (GTSM:3374) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue misses expectations

Xintec Inc., Annual General Meeting, May 27, 2021

Full year 2020 earnings released: EPS NT$6.37 (vs NT$0.67 in FY 2019)

An Intrinsic Calculation For Xintec Inc. (GTSM:3374) Suggests It's 49% Undervalued

This Xintec Inc. (GTSM:3374) Analyst Is Way More Bearish Than They Used To Be

What Is Xintec Inc.'s (GTSM:3374) Share Price Doing?

Here's Why I Think Xintec (GTSM:3374) Is An Interesting Stock

Is Xintec (GTSM:3374) Using Too Much Debt?

Investor sentiment deteriorated over the past week

The Xintec (GTSM:3374) Share Price Has Soared 412%, Delighting Many Shareholders

Market bids up stock over the past week

New 90-day high: NT$199

Does Xintec's (GTSM:3374) CEO Salary Compare Well With The Performance Of The Company?

Third quarter 2020 earnings released: EPS NT$2.21

Third quarter 2020 earnings released: EPS NT$2.20

Market bids up stock over the past week

New 90-day high: NT$135

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines